Two Sigma Securities’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$965K Buy
+6,432
New +$700K 0.08% 305
2024
Q4
Sell
-22,269
Closed -$511K 2257
2024
Q3
$511K Sell
22,269
-1,997
-8% -$56.5K 0.01% 1301
2024
Q2
$701K Buy
24,266
+7,666
+46% +$179K 0.01% 1294
2024
Q1
$342K Buy
+16,600
New +$356K ﹤0.01% 1853
2023
Q2
Sell
-15,697
Closed -$451K 2985
2023
Q1
$368K Buy
15,697
+5,244
+50% +$150K 0.01% 1505
2022
Q4
$284K Buy
10,453
+227
+2% +$10.4K 0.01% 1586
2022
Q3
$550K Buy
+10,226
New +$525K 0.02% 1029
2022
Q1
Sell
-2,060
Closed -$141K 2247
2021
Q4
$206K Buy
+2,060
New +$213K 0.01% 1074
2021
Q2
Sell
-1,340
Closed -$180K 1566
2021
Q1
$205K Buy
+1,340
New +$203K 0.01% 641

Other funds holding GH

Two Sigma Securities's GH Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Guardant Health (GH) in Q2 2026: 6,432 shares worth $965K. The stake represents 0.08% of the portfolio and ranks #305 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in GH as recently as Q3 2024.

Two Sigma Securities first reported a position in GH in Q1 2021 and has held it in 9 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Two Sigma Securities held 6,432 shares of Guardant Health worth $965K as of Q2 2026.
  • Guardant Health was a new Two Sigma Securities position in Q2 2026.
  • Guardant Health made up 0.08% of Two Sigma Securities's portfolio in Q2 2026, its #305 holding.
  • Two Sigma Securities first reported a position in Guardant Health in Q1 2021 and has held it in 9 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.